NCT05319509 Pilot Study of Virtual Reality Therapy for Students With Anxiety
| NCT ID | NCT05319509 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-04-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-04-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess changes in self-reported anxiety over the course of six virtual reality (VR) sessions and to assess changes in academic self-efficacy, as well as examine the feasibility and acceptability of a relatively short and time intensive VR intervention (i.e.,six sessions over the course of three weeks) for reducing anxiety symptoms in college students.
Eligibility Criteria
Inclusion Criteria: * enrolled in The University of Texas Health Science Center School of Public Health San Antonio regional campus * competent in English * total score of at least 3 on the Generalized Anxiety Disorder (GAD-2) Exclusion Criteria: * Currently receiving psychological treatment for anxiety symptoms, or has received treatment in the last year. * Report photosensitive epilepsy. * Report stereoscopic vision or balance problems
Contact & Investigator
Tsai Jack, PhD
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT05319509 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05319509 currently recruiting?
Yes, NCT05319509 is actively recruiting participants. Contact the research team at Jack.Tsai@uth.tmc.edu for enrollment information.
Where is the NCT05319509 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05319509 clinical trial?
NCT05319509 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Tsai Jack, PhD at The University of Texas Health Science Center, Houston. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.